PerkinElmer is a Leader in Preclinical Imaging Enabling Researchers to Visualize Disease in all its Dimensions
WHAT: PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will showcase its multimodality imaging technologies at the 2015 World Molecular Imaging Congress (WMIC) Annual Meeting. The event brings together research scientists to discuss and present cutting-edge advances in molecular imaging.
PerkinElmer's portfolio of preclinical imaging offerings include optical, microCT and PET imaging modalities, along with a wide range of in vivo imaging reagents. These solutions enable visualization in multiple dimensions, providing researchers a better understanding of disease.
"WMIC 2015 is an ideal forum for PerkinElmer to share its innovative preclinical solutions and expertise with the molecular imaging community," said Brian Kim, President, Life Sciences & Technology, PerkinElmer. "Combining modalities helps researchers monitor disease progression, determine treatment efficacy early on, and more deeply understand the metabolic changes occurring throughout disease development -- which may translate to improved health outcomes."
WHEN: September 2-5, 2015
WHERE: Hawaii Convention Center, Honolulu (Booth#409)
ON DISPLAY: PerkinElmer will showcase the following imaging technologies at WMIC 2015:
• IVIS® SpectrumCT™: an integrated optical and microCT system that enables simultaneous molecular and anatomical imaging in one platform
•Quantum™ GX microCT system: small animal microCT instrument providing high-resolution images at an X-ray dose low enough to enable true longitudinal imaging capability
•G8 PET/CT imaging system: integrates PET and CT into a bench top system built to enable preclinical workflows in a broad-range of applications
•Solaris™ Open Air Fluorescence Imaging System: designed for large animal preclinical, translational and emerging veterinary surgical research applications
•Optical imaging reagents: including the new Bioware® Brite bioluminescent oncology cell lines and fluorescence agents ImmunoPET reagents: including Zirconium-89 and Iodine-124
WORK SHOP: PerkinElmer will host the workshop Seeing Disease in a New Light: Multimodality Molecular Imaging for Translational Research Timothy C. Doyle, Ph.D., Director, Stanford Small Animal Imaging Service Center, Kevin P. Francis, Ph.D., Research Fellow, PerkinElmer Sept. 4, 8:00-9:00am
POSTERS:
PerkinElmer will deliver the following poster presentations:
•Using a brighter, red-shifted luciferase for in vivo tumor bioluminescence imaging
Aleksey Yevtodiyenko, Haoyu Mao, Kristine O. Vasquez, and Jeffrey D. Peterson
Sept. 3, 8:00-9:30am
•LBAP 060: In vivo fluorescent imaging of tumor bombesin and transferrin receptor expression as early indicators of Sorafenib efficacy in small animal models
Jeff D. Peterson, Ph.D. and Jen-Chieh Tseng
Sept. 3, 5:00-6:00pm
•P596: Open-air fluorescence imaging of tumors using the Solaris™ imaging system
Jeff Meganck, Ph.D., Jeff Peterson, Ph.D., Wael Yared, Ph.D.
Sept. 5, 1:45-2:45pm
•P569: A fluorescent agent cocktail for detecting both cholestasis and hepatocellular forms of acute drug-induced liver injury
Kristine Vasquez and Jeff D. Peterson, Ph.D.
Sept. 5, 1:45-2:45pm
•High resolution anatomical and functional CT imaging with Quantum GX imaging platform Jeff Meganck, Ph.D., James Tseng, Ph.D., Jeffrey Peterson, Ph.D. Sept. 3, 8:00-9:30am
MORE: For more information on PerkinElmer at WMIC 2015 please click here. Follow us on twitter @PKILifeScience and join the conversation around at #WMIC2015.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2014, has about 7,700 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Media Contact:
Ilene Schneider (on behalf of PerkinElmer)
Email: ileneschneider@aol.com
+1 (949)-786-6270 or +1 (949)-433-6862
Help employers find you! Check out all the jobs and post your resume.
WHAT: PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will showcase its multimodality imaging technologies at the 2015 World Molecular Imaging Congress (WMIC) Annual Meeting. The event brings together research scientists to discuss and present cutting-edge advances in molecular imaging.
PerkinElmer's portfolio of preclinical imaging offerings include optical, microCT and PET imaging modalities, along with a wide range of in vivo imaging reagents. These solutions enable visualization in multiple dimensions, providing researchers a better understanding of disease.
"WMIC 2015 is an ideal forum for PerkinElmer to share its innovative preclinical solutions and expertise with the molecular imaging community," said Brian Kim, President, Life Sciences & Technology, PerkinElmer. "Combining modalities helps researchers monitor disease progression, determine treatment efficacy early on, and more deeply understand the metabolic changes occurring throughout disease development -- which may translate to improved health outcomes."
WHEN: September 2-5, 2015
WHERE: Hawaii Convention Center, Honolulu (Booth#409)
ON DISPLAY: PerkinElmer will showcase the following imaging technologies at WMIC 2015:
• IVIS® SpectrumCT™: an integrated optical and microCT system that enables simultaneous molecular and anatomical imaging in one platform
•Quantum™ GX microCT system: small animal microCT instrument providing high-resolution images at an X-ray dose low enough to enable true longitudinal imaging capability
•G8 PET/CT imaging system: integrates PET and CT into a bench top system built to enable preclinical workflows in a broad-range of applications
•Solaris™ Open Air Fluorescence Imaging System: designed for large animal preclinical, translational and emerging veterinary surgical research applications
•Optical imaging reagents: including the new Bioware® Brite bioluminescent oncology cell lines and fluorescence agents ImmunoPET reagents: including Zirconium-89 and Iodine-124
WORK SHOP: PerkinElmer will host the workshop Seeing Disease in a New Light: Multimodality Molecular Imaging for Translational Research Timothy C. Doyle, Ph.D., Director, Stanford Small Animal Imaging Service Center, Kevin P. Francis, Ph.D., Research Fellow, PerkinElmer Sept. 4, 8:00-9:00am
POSTERS:
PerkinElmer will deliver the following poster presentations:
•Using a brighter, red-shifted luciferase for in vivo tumor bioluminescence imaging
Aleksey Yevtodiyenko, Haoyu Mao, Kristine O. Vasquez, and Jeffrey D. Peterson
Sept. 3, 8:00-9:30am
•LBAP 060: In vivo fluorescent imaging of tumor bombesin and transferrin receptor expression as early indicators of Sorafenib efficacy in small animal models
Jeff D. Peterson, Ph.D. and Jen-Chieh Tseng
Sept. 3, 5:00-6:00pm
•P596: Open-air fluorescence imaging of tumors using the Solaris™ imaging system
Jeff Meganck, Ph.D., Jeff Peterson, Ph.D., Wael Yared, Ph.D.
Sept. 5, 1:45-2:45pm
•P569: A fluorescent agent cocktail for detecting both cholestasis and hepatocellular forms of acute drug-induced liver injury
Kristine Vasquez and Jeff D. Peterson, Ph.D.
Sept. 5, 1:45-2:45pm
•High resolution anatomical and functional CT imaging with Quantum GX imaging platform Jeff Meganck, Ph.D., James Tseng, Ph.D., Jeffrey Peterson, Ph.D. Sept. 3, 8:00-9:30am
MORE: For more information on PerkinElmer at WMIC 2015 please click here. Follow us on twitter @PKILifeScience and join the conversation around at #WMIC2015.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2014, has about 7,700 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
Media Contact:
Ilene Schneider (on behalf of PerkinElmer)
Email: ileneschneider@aol.com
+1 (949)-786-6270 or +1 (949)-433-6862
Help employers find you! Check out all the jobs and post your resume.
